BackAstellas Pharma Overview

Astellas Pharma Long Term Debt

Latest long-term debt for ALPMY: $320B.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$317.89B
↓ 43.04% YoYΔ $-240.19B vs prior year quarter

Peer trimmed avg / median

Loading

Astellas Pharma Long Term Debt History

Loading

Astellas Pharma vs. peers: Long Term Debt Comparison

Loading

Astellas Pharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Astellas Pharma (ALPMY) FAQ

As of the most recent data (June 2026), ALPMY shows a long-term debt of $320B. That compares with $560B in the prior-year period — down 43.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ALPMY's long-term debt is now $320B (was $560B) — a 43.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Astellas Pharma is outperforming or lagging.

Tracking ALPMY's long-term debt over time shows whether Astellas Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $320B That compares with $560B in the prior-year period — down 43.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Astellas Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $320B) with ownership activity and broader fundamentals.

Astellas Pharma's long-term debt is $320B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.